The Future of Cancer Screening
Thanks to our Gold Sponsor, Exact Sciences, this complimentary webinar offers an exciting opportunity to explore one of the leading advancements in cancer screening today.
Multi-cancer early detection (MCED) testing represents a promising new frontier in cancer screening. This webinar will provide an overview of Cancerguard™, a multi-biomarker blood-based MCED test designed to detect signals associated with multiple cancers from a single blood draw. Participants will explore the science behind MCED technology, review current clinical evidence, and discuss the potential role of MCED testing within existing cancer screening paradigms.
